Literature DB >> 11226375

Extracellular adenosine-induced apoptosis in mouse neuroblastoma cells: studies on involvement of adenosine receptors and adenosine uptake.

S M Schrier1, E W van Tilburg, H van der Meulen, A P Ijzerman, G J Mulder, J F Nagelkerke.   

Abstract

The induction of apoptosis by adenosine was studied in the mouse neuroblastoma cell line N1E-115. Apoptosis was characterized by fluorescence and electron microscopy, fluorescence-activated cell sorter (FACS) analysis, and caspase activity assays. A sixteen-hour exposure to 100 microM of adenosine led to chromatin condensation and caspase activation. However, selective agonists for all four adenosine receptors were ineffective. Caspase activation could be blocked partially by an inhibitor of the nucleoside transporter, dipyridamole, and completely by uridine, a competing substrate for adenosine transport. 2'-Deoxycoformycin, an inhibitor of adenosine deaminase, enhanced caspase activation by adenosine but had no effect by itself. Caspase activation could be blocked by 5'-amino-5'-deoxyadenosine, which inhibits the phosphorylation of adenosine by adenosine kinase. These results indicate that adenosine receptors are not involved in adenosine-induced apoptosis in N1E-115 cells, but that uptake of adenosine and its subsequent phosphorylation is required.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11226375     DOI: 10.1016/s0006-2952(00)00573-6

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  16 in total

1.  Pharmacological and biochemical characterization of adenosine receptors in the human malignant melanoma A375 cell line.

Authors:  S Merighi; K Varani; S Gessi; E Cattabriga; V Iannotta; C Ulouglu; E Leung; P A Borea
Journal:  Br J Pharmacol       Date:  2001-11       Impact factor: 8.739

Review 2.  Anticancer effect of adenosine on gastric cancer via diverse signaling pathways.

Authors:  Ayako Tsuchiya; Tomoyuki Nishizaki
Journal:  World J Gastroenterol       Date:  2015-10-21       Impact factor: 5.742

3.  Apoptosis induced by nucleosides in the human hepatoma HepG2.

Authors:  Suh-Ching Yang; Che-Lin Chiu; Chi-Chang Huang; Jiun-Rong Chen
Journal:  World J Gastroenterol       Date:  2005-10-28       Impact factor: 5.742

4.  Adenosine and deoxyadenosine induces apoptosis in oestrogen receptor-positive and -negative human breast cancer cells via the intrinsic pathway.

Authors:  M Hashemi; F Karami-Tehrani; S Ghavami; S Maddika; M Los
Journal:  Cell Prolif       Date:  2005-10       Impact factor: 6.831

Review 5.  Purinergic signalling and cancer.

Authors:  Geoffrey Burnstock; Francesco Di Virgilio
Journal:  Purinergic Signal       Date:  2013-12       Impact factor: 3.765

6.  Extracellular ATP and adenosine induce cell apoptosis of human hepatoma Li-7A cells via the A3 adenosine receptor.

Authors:  Long T Wen; Aileen F Knowles
Journal:  Br J Pharmacol       Date:  2003-10-06       Impact factor: 8.739

7.  Extracellular adenosine induces apoptosis in Caco-2 human colonic cancer cells by activating caspase-9/-3 via A(2a) adenosine receptors.

Authors:  Yoshiyuki Yasuda; Masaru Saito; Takehira Yamamura; Takahiro Yaguchi; Tomoyuki Nishizaki
Journal:  J Gastroenterol       Date:  2009-01-22       Impact factor: 7.527

Review 8.  The Signaling Pathways Involved in Chondrocyte Differentiation and Hypertrophic Differentiation.

Authors:  Jianmei Li; Shiwu Dong
Journal:  Stem Cells Int       Date:  2016-12-15       Impact factor: 5.443

9.  Adenosine protects against suicidal erythrocyte death.

Authors:  Olivier M Niemoeller; Peter J Bentzen; Elisabeth Lang; Florian Lang
Journal:  Pflugers Arch       Date:  2007-02-07       Impact factor: 4.458

10.  Intracellular ATP concentration contributes to the cytotoxic and cytoprotective effects of adenosine.

Authors:  Shujue Li; Xiaofen Li; Haiping Guo; Shouting Liu; Hongbiao Huang; Ningning Liu; Changshan Yang; Ping Tang; Jinbao Liu
Journal:  PLoS One       Date:  2013-10-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.